Version 5.4
Mus musculus Protein: Cbln2
Summary
InnateDB Protein IDBP-163018.6
Last Modified 2014-10-13 [Report errors or provide feedback]
Gene Symbol Cbln2
Protein Name cerebellin 2 precursor protein
Synonyms 6330593N19Rik; A730004O05;
Species Mus musculus
Ensembl Protein ENSMUSP00000068863
InnateDB Gene IDBG-163016 (Cbln2)
Protein Structure
UniProt Annotation
Function May play role in synaptogenesis induction. {ECO:0000269PubMed:21410790}.
Subcellular Localization Secreted {ECO:0000269PubMed:17030622, ECO:0000269PubMed:17331201}.
Disease Associations
Tissue Specificity Expressed in various brain regions with higher levels in the olfactory bulb, cerebral cortex, certain thalamic and hypothalamic nuclei, superior and inferior colliculi and some brainstem nuclei. {ECO:0000269PubMed:16930405}.
Comments
Interactions
Number of Interactions This gene and/or its encoded proteins are associated with 0 experimentally validated interaction(s) in this database.
Gene Ontology

Molecular Function
Accession GO Term
GO:0005515 protein binding
Biological Process
GO:0051965 positive regulation of synapse assembly
Cellular Component
GO:0005615 extracellular space
Protein Structure and Domains
PDB ID MGI:88282
InterPro IPR001073 Complement C1q protein
IPR008983 Tumour necrosis factor-like domain
PFAM PF00386
PRINTS PR00007
PIRSF
SMART SM00110
TIGRFAMs
Post-translational Modifications
Modification
Cross-References
SwissProt Q8BGU2
PhosphoSite PhosphoSite-Q8BGU2
TrEMBL
UniProt Splice Variant
Entrez Gene 12405
UniGene Mm.70775
RefSeq XP_006526510
MGI ID
MGI Symbol Cbln2
OMIM
CCDS CCDS29388
HPRD
IMGT
EMBL AK032112 AK042555 BC055682
GenPept AAH55682 BAC27710 BAC31290

If you use InnateDB for your research, please cite the following publication:

Breuer et al., InnateDB: systems biology of innate immunity and beyond - recent updates and continuing curation. Nucl. Acids Res. (2013) 41 (D1) 

InnateDB is being developed jointly by the Brinkman Laboratory (Simon Fraser University, British Columbia, Canada), the Hancock Laboratory (University of British Columbia, Vancouver, British Columbia) and the Lynn EMBL Australia Group (South Australian Health & Medical Research Institute and Flinders University, Adelaide, Australia).

Funding is currently provided by Allergen and EMBL Australia. Previous funding has been provided by Genome Canada, the Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative and by Teagasc. InnateDB curated interactions are licensed under the Design Science License. All other data is licensed under the terms of the originating database. Contact: innatedb-mail@sfu.ca